---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-102170"
form_type: "8-K"
ticker: "CRMD"
cik: "0001410098"
company_name: "CorMedix Inc."
filed_at: "2024-11-25T23:59:59+00:00"
generated_at: "2026-05-29T18:46:38.544515+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# CorMedix shareholders approve stock plan amendment increasing authorized shares; all director nominees elected

## Summary
- Plan amendment to increase share authorization under 2019 Omnibus Stock Incentive Plan approved with 16.5M FOR, 2.8M AGAINST, 0.8M abstain.
- All 7 director nominees elected: Dillione, Duncan, Dunton, Kaplan, Lefkowitz, Stewart, Todisco – each received >15.8M FOR votes.
- Non-binding advisory vote on 2023 executive compensation passed (FOR: 17.5M, AGAINST: 2.4M).
- Ratification of Marcum LLP as auditor for FY2024 approved with 40.5M FOR, 215K against, 370K abstain.

## SEC filing metadata
- accession: 0001213900-24-102170
- form_type: 8-K
- ticker: CRMD
- cik: 0001410098
- company_name: CorMedix Inc.
- filed_at: 2024-11-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1410098/000121390024102170/0001213900-24-102170-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1410098/000121390024102170/ea0222389-8k_cormedix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-102170
- JSON: https://secwatch.observer/filing/0001213900-24-102170.json
- Plain text: https://secwatch.observer/filing/0001213900-24-102170.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.